| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal | Frank Vinluan | 12/12/19 | Boulder/Denver |
| With Reverse Merger, Miragen to Go Public, Get $40M Boost From Investors | Ben Fidler | 11/01/16 | Boulder/Denver |
| MiRagen Lands $41M for MicroRNA Drugs in Cancer, Fibrosis | David Holley | 11/10/15 | Boulder/Denver |
| MiRagen Therapeutics Garners $41,000,000 Series C Funding Round | VentureDeal | 11/10/15 | Boulder/Denver |
| MiRagen Therapeutics Receives $8,499,962 New Financing Round | VentureDeal | 02/18/15 | Boulder/Denver |
| MiRagen Therapeutics Lands $7,000,000 Series B Round | VentureDeal | 07/01/14 | Boulder/Denver |
| MiRagen Therapeutics Raises $7M, Extends Deal with France’s Servier | Michael Davidson | 06/26/14 | Boulder/Denver |
| MiRagen Therapeutics Garners $20,000,000 Series B Funding Round | VentureDeal | 04/24/12 | Boulder/Denver |
| MiRagen Therapeutics Obtains $6,000,000 New Funding Round | VentureDeal | 01/04/12 | Boulder/Denver |
| Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs | Luke Timmerman | 12/12/11 | Seattle |
| Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names | Luke Timmerman | 08/16/10 | Seattle |
| Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash | Luke Timmerman | 04/26/10 | Seattle |
| Joule Debuts Biofuel Technology, Genzyme Cleans House, Avila Banks $30M, & More Boston-Area Life Sciences News | Rebecca Zacks | 07/29/09 | Boston |
| Archemix Signs MicroRNA Deal | Luke Timmerman | 07/23/09 | Boston |
| Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis | Luke Timmerman | 01/21/09 | San Diego |
| Takeda and Alnylam Join Forces, Carl Icahn Makes His Case, New England Biotech is Hot (Duh), & More Life Sciences News | Rebecca Zacks | 05/29/08 | Boston |
| Evergreen Rakes in the Green, NxStage Plans Two-Stage Deal, Atlas Places Big Bet on MicroRNA, & More Deals News | Rebecca Zacks | 05/27/08 | Boston |
